Drugs Health Medical

Oral semaglutide reduces HbA1c, weight in Type 2 diabetics, study reveals

HQ Team June 8, 2023: A new study analyzing the PIONEER (Peptide Innovation for Early Diabetes Treatment) clinical trials data has revealed the.

Read More
Drugs Health Medical Pharma

Japan’s Eisai seeks marketing nod for Alzheimer’s drug in South Korea

HQ Team June 8, 2023: Japan’s Eisai Co and Biogen Inc., have submitted a marketing authorisation application with the South Korean health authority.

Read More
Drugs Health Medical Pharma

EU unveils €1.2 billion plan to tackle mental health crisis

HQ Team June 8, 2023: The European Union has announced a 1.23 billion euro initiative to prevent mental health issues and find affordable.

Read More
Drugs Health Medical

Ingestible pill camera offers real-time control for gastrointestinal exploration

HQ Team June 7, 2023: A team of researchers at George Washington University has developed an ingestible pill camera that can be “driven”.

Read More
Drugs Health Medical Uncategorized

Risks of overdoing Niacin or vitamin B3

HQ Team June 7, 2023: Vitamins supplements have become a routine part of our health regime and since these pills are not as.

Read More
Drugs Health Medical

Parkinson’s drug Ropinirole shows promise as potential treatment for ALS, study finds

HQ Team June 7, 2023: Ropinirole, a drug already approved for the treatment of Parkinson’s disease, has shown potential as a treatment for.

Read More
Climate Health Uncategorized

Indoor plants can remove toxic pollutants in hours, says study

HQ Team June 6, 2023: A little bit of greenery indoors goes a long way in improving the environment both physically and mentally..

Read More
Health Medical

Groundbreaking intervention reduces severe postpartum haemorrhage by 60%, study reveals

HQ Team June 5, 2023: Each year, approximately 14 million women are affected by Postpartum haemorrhage (PPH) PPH, with around 70,000 cases resulting.

Read More
Drugs Health Medical Pharma

AstraZeneca’s drug cuts risk of lung cancer death by 51%, trials show

HQ Team June 5, 2023: AstraZeneca’s lung cancer drug, Tagrisso, reduced the risk of death by 51% in the early stages of the.

Read More
Drugs Health Medical Pharma

Novartis’ Kisqali shows 25% reduction in breast cancer recurrence

HQ Team June 3, 2023: Novartis breast cancer drug Kisqali cut the risk of recurrence of the disease by more than 25% in.

Read More